## 3 Results

Table 3: Serum lipid profile, atherogenic index, TCH/HDL and TAG/HDL ratios of rats after 4 (marked as \(\frac{1}{2}\)) and 8 weeks of feeding: AIN\({}_{\text{ch}}\), WD\({}_{\text{ch}}\) (Western diet) or LCHP\({}_{\text{ch}}\) (low-carbohydrate–high-protein) diets, enriched with 1% cholesterol. \begin{table}
\begin{tabular}{l c c c} \hline \hline \multirow{2}{*}{**Parameter [Unit]**} & \multicolumn{4}{c}{**Experimental Groups**} \\ \cline{2-4}  & **AIN\({}_{\text{ch}}\)** & **WD\({}_{\text{ch}}\)** & **LCHP\({}_{\text{ch}}\)** \\ \hline Uric acid [mg/dL] & 4.1 \({}^{\text{a}}\)\(\pm\) 2.0 & 8.8 \({}^{\text{b}}\)\(\pm\) 3.4 & 5.8 \({}^{\text{ab}}\)\(\pm\) 2.2 \\ ALT [U/L] & 33.4 \({}^{\text{a}}\)\(\pm\) 8.7 & 41.9 \({}^{\text{ab}}\)\(\pm\) 11.9 & 49.5 \({}^{\text{b}}\)\(\pm\) 6.5 \\ AST [U/L] & 62.9 \({}^{\text{a}}\)\(\pm\) 22.1 & 62.2 \({}^{\text{a}}\)\(\pm\) 39.8 & 74.5 \({}^{\text{a}}\)\(\pm\) 16.7 \\ Glucose fasting [mg/dL] & 100 \({}^{\text{a}}\)\(\pm\) 10 & 110 \({}^{\text{a}}\)\(\pm\) 12 & 106 \({}^{\text{a}}\)\(\pm\) 10 \\ Creatine [mmol/L] & 106.7 \({}^{\text{a}}\)\(\pm\) 16.5 & 121.7 \({}^{\text{a}}\)\(\pm\) 20.4 & 125.9 \({}^{\text{a}}\)\(\pm\) 16.5 \\ \hline \hline \end{tabular} Data are means \(\pm\) SD. The means marked with letters \({}^{\text{a}}\) and \({}^{\text{b}}\) (in each line) are significantly different (\(p<0.05\)).  
\end{table} 
Table 4: The concentration/activity of examined biochemical parameters in blood of rats after 8 weeks of feeding: AIN\({}_{\text{ch}}\), WD\({}_{\text{ch}}\) (Western diet) or LCHP\({}_{\text{ch}}\) (low-carbohydrate–high-protein) diets, enriched with 1% cholesterol. Figure 4: Liver fat (%) of rats after 8 weeks of feeding (AIN\({}_{\rm ch}\), WD\({}_{\rm ch}\) or LCHP\({}_{\rm ch}\) diets), enriched with 1% cholesterol. The means marked with letters a and b are significantly different (\(p<0.05\)). Figure 3: Comparison of fatty acid share (%) (SFA, MUFA, PUFA) in adipose tissue of rats depending on their diet (AIN\({}_{\rm ch}\), WD\({}_{\rm ch}\), LCHP\({}_{\rm ch}\)). The means marked with letters a and b are significantly different (\(p<0.05\)). \begin{table}
\begin{tabular}{l c c c c} \hline  & \multicolumn{3}{c}{**Experimental Groups**} \\  & \multicolumn{1}{c}{**Fatty Acid**} & \multicolumn{3}{c}{**AIN\({}_{\rm ch}\)**} & \multicolumn{1}{c}{**WD\({}_{\rm ch}\)**} & \multicolumn{1}{c}{**LCHP\({}_{\rm ch}\)**} \\ \hline Myristic acid & C14:0 & 1.27 \({}^{\rm a}\)\(\pm\) 0.15 & 7.22 \({}^{\rm b}\)\(\pm\) 0.63 & 8.28 \({}^{\rm b}\)\(\pm\) 0.21 \\ Palmitic acid & C16:0 & 25.41 \({}^{\rm a}\)\(\pm\) 3.22 & 32.55 \({}^{\rm b}\)\(\pm\) 0.89 & 31.80 \({}^{\rm b}\)\(\pm\) 1.11 \\ Palmitic acid & C16:1 & 7.01 \({}^{\rm a}\)\(\pm\) 1.53 & 9.83 \({}^{\rm b}\)\(\pm\) 0.66 & 7.65 \({}^{\rm ab}\)\(\pm\) 0.56 \\ Margaric acid & C17:0 & 0.09 \({}^{\rm a}\)\(\pm\) 0.03 & 0.32 \({}^{\rm b}\)\(\pm\) 0.07 & 0.49 \({}^{\rm c}\)\(\pm\) 0.05 \\ Stearic acid & C18:0 & 3.19 \({}^{\rm a}\)\(\pm\) 0.80 & 3.31 \({}^{\rm b}\)\(\pm\) 0.72 & 4.00 \({}^{\rm b}\)\(\pm\) 0.40 \\ Oleic acid & C18:1 & 32.66 \({}^{\rm a}\)\(\pm\) 2.23 & 43.90 \({}^{\rm b}\)\(\pm\) 0.84 & 43.95 \({}^{\rm b}\)\(\pm\) 1.20 \\ Linoleic acid \(n-6\) & C18:2 & 27.97 \({}^{\rm a}\)\(\pm\) 7.08 & 1.65 \({}^{\rm b}\)\(\pm\) 0.39 & 2.22 \({}^{\rm b}\)\(\pm\) 0.31 \\ Linoleic acid & C18:2 & 0.00 \({}^{\rm a}\)\(\pm\) 0.00 & 0.45 \({}^{\rm b}\)\(\pm\) 0.13 & 0.66 \({}^{\rm b}\)\(\pm\) 0.11 \\ Linoleic acid & C18:3 & 2.37 \({}^{\rm a}\)\(\pm\) 0.56 & 0.27 \({}^{\rm b}\)\(\pm\) 0.10 & 0.34 \({}^{\rm b}\)\(\pm\) 0.12 \\ \hline \end{tabular} Data are means \(\pm\) SD. The means marked with letters \({}^{\rm a}\), \({}^{\rm b}\) and \({}^{\rm c}\) (in each line) are significantly different (\(p<0.05\)).  
\end{table} 
Table 5: Fatty acid profile (%) in adipose tissue of rats after 8 weeks of feeding: AIN\({}_{\rm ch}\), WD\({}_{\rm ch}\) (Western diet) or LCHP\({}_{\rm ch}\) (low-carbohydrate–high-protein) diets enriched with 1% cholesterol.